Larry G. Edwards Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Larry G. Edwards.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Larry G. Edwards. Larry G. Edwards is Chief Executive Officer in LA JOLLA PHARMACEUTICAL CO ($LJPC) and Chief Operating Officer in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and President and CEO in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and See Remarks in TETRAPHASE PHARMACEUTICALS INC ($TTPH).
Latest Insider Trading Transactions of Larry G. Edwards
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Option Exercise | A | 3.76 | 358 | 1,346 | 358 | |
| May 18 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Grant | A | 3.20 | 358 | 1,144 | 984 | 626 to 984 (+57.19 %) |
| May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Option Exercise | A | 4.44 | 304 | 1,350 | 304 | |
| May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Grant | A | 3.77 | 304 | 1,147 | 626 | 322 to 626 (+94.41 %) |
| Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Option Exercise | A | 4.18 | 322 | 1,346 | 322 | |
| Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Grant | A | 3.55 | 322 | 1,144 | 322 | 0 to 322 |
| Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Option Exercise | A | 4.18 | 322 | 1,346 | 322 | |
| Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Grant | A | 3.55 | 322 | 1,144 | 322 | 0 to 322 |
| Dec 14 2020 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Option Exercise | A | 4.53 | 278,350 | 1,260,926 | 278,350 | |
| Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Option Exercise | D | 0.00 | 1,875 | 0 | 0 | |
| Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Option Exercise | D | 0.00 | 2,025 | 0 | 0 | |
| Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Option Exercise | D | 0.00 | 640 | 0 | 0 | |
| Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Option Exercise | D | 0.00 | 7,500 | 0 | 0 | |
| Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Option Exercise | D | 0.00 | 6,595 | 0 | 0 | |
| Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Option Exercise | D | 0.00 | 1,374 | 0 | 0 | |
| Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Option Exercise | D | 0.00 | 623 | 0 | 0 | |
| Jul 29 2020 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | See Remarks | Sell | U | 0.00 | 1,346 | 0 | 0 | 1.3 K to 0 (-100.00 %) |
| Aug 02 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | President and CEO | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
| Aug 02 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | President and CEO | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Aug 02 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | President and CEO | Grant | A | 0.00 | 4,148 | 0 | 54,937 | 50.8 K to 54.9 K (+8.17 %) |
| Aug 02 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | President and CEO | Grant | A | 0.00 | 13,913 | 0 | 50,789 | 36.9 K to 50.8 K (+37.73 %) |
| Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | Chief Operating Off ... | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
| Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | Chief Operating Off ... | Option Exercise | A | 0.00 | 45,000 | 0 | 45,000 | |
| Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | Chief Operating Off ... | Grant | A | 0.00 | 2,509 | 0 | 36,876 | 34.4 K to 36.9 K (+7.30 %) |
| Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | Chief Operating Off ... | Grant | A | 0.00 | 2,058 | 0 | 34,367 | 32.3 K to 34.4 K (+6.37 %) |
| Jan 18 2019 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | Chief Operating Off ... | Grant | A | 0.00 | 4,277 | 0 | 32,309 | 28 K to 32.3 K (+15.26 %) |
| Apr 04 2018 | TTPH | TETRAPHASE PHARMAC ... | Edwards Larry G. | Chief Operating Off ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 |
Page: 1